Proove Biosciences, Inc.

Proove Biosciences, Inc. The Leader in Precision Pain Medicine - Advanced Algorithms of Genetic & Phenotypic Factors Proove also has offices in Irvine, California, and Orem, Utah.

Proove Genomics is a molecular diagnostics company delivering on the promise of precision pain medicine based on its award-winning history and research. Proove performs advanced laboratory testing in its CLIA-certified laboratory, and then analyzes that information, along with a patient’s phenotypic factors such as age, gender, ethnicity, and clinically-validated assessments of physical function, mental health, and quality of life using advanced mathematical algorithms, to develop and deliver unique profiles to better understand and improve the treatment of pain. Our research has been published in peer-reviewed journals and recognized by leading medical societies such as the American Academy of Pain Medicine, American Society of Interventional Pain Physicians, American Academy of Neurology, American Society of Regional Anesthesia, American Academy of Addiction Medicine, and more. Proove operates a state-of-the-art CLIA-certified laboratory in Houston, Texas near the world’s largest life sciences destination – the Texas Medical Center – with 8 different academic and research institutions, not to mention the 21 different hospitals.

01/30/2023

Brian Meshkin literally got his day in court, and he finally feels vindicated. U.S. District Judge Josephine Staton of the Central District of California on Dec. 22 threw out all federal charges against Meshkin.

Former Proove CEO and founder, Brian Meshkin, explains the impact of new ICD-11 chronic pain classifications
06/05/2019

Former Proove CEO and founder, Brian Meshkin, explains the impact of new ICD-11 chronic pain classifications

On May 25, 2019, the World Health Organization (WHO) adopted ICD-11 which includes a new classification system for the world's most prevalent and expensive health condition - chronic pain According to a press release from the International Association for the Study of Pain (IASP), the new ICD-11 cla

The Truth About Proove Biosciences - backed up by empirical evidence. Not the lies and false allegations, but the docume...
02/26/2018

The Truth About Proove Biosciences - backed up by empirical evidence. Not the lies and false allegations, but the documented facts.

THE TRUTH ABOUT PROOVE BIOSCIENCES NOT THE FALSE STORY BUT THE REAL, EMPIRICAL FACTS The Real Story 2017 was a year when we all saw truth come under attack. Whether in politics or business, “fake news” became mainstream media and many people and companies became victims. One such ...

Study of Proove Opioid Risk Shows Positive Patient Benefits in over 90% of Patients https://t.co/5bArdznx9P via PR Newsw...
06/21/2017

Study of Proove Opioid Risk Shows Positive Patient Benefits in over 90% of Patients https://t.co/5bArdznx9P via PR Newswire

Clinical Study Demonstrates Accuracy Of Proove Opioid Risk® To Predict Opioid Abuse http://ow.ly/UYN430cCzRx
06/15/2017

Clinical Study Demonstrates Accuracy Of Proove Opioid Risk® To Predict Opioid Abuse http://ow.ly/UYN430cCzRx

Proove responds to   by STAT with verifiable facts to refute lies - enough is enough! http://ow.ly/iNCG30crBXT
06/09/2017

Proove responds to by STAT with verifiable facts to refute lies - enough is enough! http://ow.ly/iNCG30crBXT

Address

655 W Mitchell Street
Arlington, TX
76010

Alerts

Be the first to know and let us send you an email when Proove Biosciences, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category